HSP90B1 and breast carcinoma: Utilizing the CPTAC database, researchers compared the phosphorylation levels of HSP90B1 in normal and primary tumour tissues of patients with UCEC, breast cancer, clear cell RCC, colon cancer, LUAD, and ovarian cancer, revealing significant differences.